Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, Pancreatic and Hepatic Oncology Research, and Cancer Immunotherapy and Biomarkers.
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial
Detection of Human Brain Cancers using Genomic and Immune Cell Characterization of Cerebrospinal Fluid through CSF-BAM
A Blood-Based Assay for Detection of Patients with Advanced Adenomas
Circulating tumor DNA analysis informing adjuvant chemotherapy in locally advanced rectal cancer: The randomized AGITG DYNAMIC-Rectal study.
Machine learning to detect the SINEs of cancer
Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape
The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study
Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands
Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
Prognostic significance of postsurgery circulating tumor <scp>DNA</scp> in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies
Assessing aneuploidy with repetitive element sequencing
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer
Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer
A multimodality test to guide the management of patients with a pancreatic cyst
The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cancer patients with nonspecific findings on standard investigations
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study
Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers
Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
Detection of aneuploidy in patients with cancer through amplification of long interspersed nucleotide elements (LINEs)
Serial circulating tumor DNA (ctDNA) analysis as a prognostic marker and a real-time indicator of adjuvant chemotherapy (CT) efficacy in stage III colon cancer (CC).
Circulating tumor DNA as a prognostic biomarker in early stage pancreatic cancer.
Cancer-Associated Mutations in Endometriosis without Cancer
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
Bisulfite-converted duplexes for the strand-specific detection and quantification of rare mutations
Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters